Cargando…

Defining functional variants associated with Alzheimer’s disease in the induced immune response

Defining the mechanisms involved in the aetiology of Alzheimer’s disease from genome-wide association studies alone is challenging since Alzheimer’s disease is polygenic and most genetic variants are non-coding. Non-coding Alzheimer’s disease risk variants can influence gene expression by affecting...

Descripción completa

Detalles Bibliográficos
Autores principales: Harwood, Janet C, Leonenko, Ganna, Sims, Rebecca, Escott-Price, Valentina, Williams, Julie, Holmans, Peter
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8087896/
https://www.ncbi.nlm.nih.gov/pubmed/33959712
http://dx.doi.org/10.1093/braincomms/fcab083
_version_ 1783686751497224192
author Harwood, Janet C
Leonenko, Ganna
Sims, Rebecca
Escott-Price, Valentina
Williams, Julie
Holmans, Peter
author_facet Harwood, Janet C
Leonenko, Ganna
Sims, Rebecca
Escott-Price, Valentina
Williams, Julie
Holmans, Peter
author_sort Harwood, Janet C
collection PubMed
description Defining the mechanisms involved in the aetiology of Alzheimer’s disease from genome-wide association studies alone is challenging since Alzheimer’s disease is polygenic and most genetic variants are non-coding. Non-coding Alzheimer’s disease risk variants can influence gene expression by affecting miRNA binding and those located within enhancers and within CTCF sites may influence gene expression through alterations in chromatin states. In addition, their function can be cell-type specific. They can function specifically in microglial enhancers thus affecting gene expression in the brain. Hence, transcriptome-wide association studies have been applied to test the genetic association between disease risk and cell-/tissue-specific gene expression. Many Alzheimer’s disease-associated loci are involved in the pathways of the innate immune system. Both microglia, the primary immune cells of the brain, and monocytes which can infiltrate the brain and differentiate into activated macrophages, have roles in neuroinflammation and β‐amyloid clearance through phagocytosis. In monocytes the function of regulatory variants can be context-specific after immune stimulation. To dissect the variants associated with Alzheimer’s disease in the context of monocytes, we utilized data from naïve monocytes and following immune stimulation in vitro, in combination with genome-wide association studies of Alzheimer’s disease in transcriptome-wide association studies. Of the nine genes with statistically independent transcriptome-wide association signals, seven are located in known Alzheimer’s disease risk loci: BIN1, PTK2B, SPI1, MS4A4A, MS4A6E, APOE and PVR. The transcriptome-wide association signal for MS4A6E, PTK2B and PVR and the direction of effect replicated in an independent genome-wide association studies. Our analysis identified two novel candidate genes for Alzheimer’s disease risk, LACTB2 and PLIN2/ADRP. LACTB2 replicated in a transcriptome-wide association study using independent expression weights. LACTB2 and PLIN2/ADRP are involved in mitochondrial function and lipid metabolism, respectively. Comparison of transcriptome-wide association study results from monocytes, whole blood and brain showed that the signal for PTK2B is specific to blood and MS4A6E is specific to LPS stimulated monocytes.
format Online
Article
Text
id pubmed-8087896
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Oxford University Press
record_format MEDLINE/PubMed
spelling pubmed-80878962021-05-05 Defining functional variants associated with Alzheimer’s disease in the induced immune response Harwood, Janet C Leonenko, Ganna Sims, Rebecca Escott-Price, Valentina Williams, Julie Holmans, Peter Brain Commun Original Article Defining the mechanisms involved in the aetiology of Alzheimer’s disease from genome-wide association studies alone is challenging since Alzheimer’s disease is polygenic and most genetic variants are non-coding. Non-coding Alzheimer’s disease risk variants can influence gene expression by affecting miRNA binding and those located within enhancers and within CTCF sites may influence gene expression through alterations in chromatin states. In addition, their function can be cell-type specific. They can function specifically in microglial enhancers thus affecting gene expression in the brain. Hence, transcriptome-wide association studies have been applied to test the genetic association between disease risk and cell-/tissue-specific gene expression. Many Alzheimer’s disease-associated loci are involved in the pathways of the innate immune system. Both microglia, the primary immune cells of the brain, and monocytes which can infiltrate the brain and differentiate into activated macrophages, have roles in neuroinflammation and β‐amyloid clearance through phagocytosis. In monocytes the function of regulatory variants can be context-specific after immune stimulation. To dissect the variants associated with Alzheimer’s disease in the context of monocytes, we utilized data from naïve monocytes and following immune stimulation in vitro, in combination with genome-wide association studies of Alzheimer’s disease in transcriptome-wide association studies. Of the nine genes with statistically independent transcriptome-wide association signals, seven are located in known Alzheimer’s disease risk loci: BIN1, PTK2B, SPI1, MS4A4A, MS4A6E, APOE and PVR. The transcriptome-wide association signal for MS4A6E, PTK2B and PVR and the direction of effect replicated in an independent genome-wide association studies. Our analysis identified two novel candidate genes for Alzheimer’s disease risk, LACTB2 and PLIN2/ADRP. LACTB2 replicated in a transcriptome-wide association study using independent expression weights. LACTB2 and PLIN2/ADRP are involved in mitochondrial function and lipid metabolism, respectively. Comparison of transcriptome-wide association study results from monocytes, whole blood and brain showed that the signal for PTK2B is specific to blood and MS4A6E is specific to LPS stimulated monocytes. Oxford University Press 2021-04-19 /pmc/articles/PMC8087896/ /pubmed/33959712 http://dx.doi.org/10.1093/braincomms/fcab083 Text en © The Author(s) (2021). Published by Oxford University Press on behalf of the Guarantors of Brain. https://creativecommons.org/licenses/by/4.0/This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) ), which permits unrestricted reuse, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Original Article
Harwood, Janet C
Leonenko, Ganna
Sims, Rebecca
Escott-Price, Valentina
Williams, Julie
Holmans, Peter
Defining functional variants associated with Alzheimer’s disease in the induced immune response
title Defining functional variants associated with Alzheimer’s disease in the induced immune response
title_full Defining functional variants associated with Alzheimer’s disease in the induced immune response
title_fullStr Defining functional variants associated with Alzheimer’s disease in the induced immune response
title_full_unstemmed Defining functional variants associated with Alzheimer’s disease in the induced immune response
title_short Defining functional variants associated with Alzheimer’s disease in the induced immune response
title_sort defining functional variants associated with alzheimer’s disease in the induced immune response
topic Original Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8087896/
https://www.ncbi.nlm.nih.gov/pubmed/33959712
http://dx.doi.org/10.1093/braincomms/fcab083
work_keys_str_mv AT harwoodjanetc definingfunctionalvariantsassociatedwithalzheimersdiseaseintheinducedimmuneresponse
AT leonenkoganna definingfunctionalvariantsassociatedwithalzheimersdiseaseintheinducedimmuneresponse
AT simsrebecca definingfunctionalvariantsassociatedwithalzheimersdiseaseintheinducedimmuneresponse
AT escottpricevalentina definingfunctionalvariantsassociatedwithalzheimersdiseaseintheinducedimmuneresponse
AT williamsjulie definingfunctionalvariantsassociatedwithalzheimersdiseaseintheinducedimmuneresponse
AT holmanspeter definingfunctionalvariantsassociatedwithalzheimersdiseaseintheinducedimmuneresponse